Piramal Pharma Limited Takes Major Step Towards Sustainability
Piramal Pharma Limited is making waves in sustainability initiatives by converting their coal-fired steam boiler at the Digwal facility to operate on biomass briquettes. This transition is a significant advancement in their commitment to reducing carbon emissions and improving environmental responsibility.
Impact on Greenhouse Gas Emissions
This strategic conversion is expected to eliminate around 24,000 tonnes of carbon dioxide equivalent (tCO2e) in greenhouse gas emissions annually. Such efforts support the company's broader sustainability goal of reducing Scope 1 and 2 emissions by 42% by 2030. This notable reduction represents about 17% of the total emissions from the company, showcasing their serious approach towards carbon neutrality.
Setting Industry Standards with Sustainable Practices
By adopting biomass briquettes, Piramal Pharma Limited is not just improving its operations but raising the bar in the pharmaceutical industry. This innovative step reflects their dedication to establishing sustainable manufacturing practices that can serve as a benchmark for others in the sector. The conversion not only supports the environment but also promotes the usage of renewable energy sources.
About Piramal Pharma Limited
Piramal Pharma Limited, incorporated as a premier pharmaceutical entity, is well-known for its commitment to innovation and excellence in manufacturing. With a robust focus on sustainability, they strive to implement practices that not only benefit their business operations but also contribute positively to the environment and society at large.
Leadership Impact
Under the guidance of experienced leaders like Nandini Piramal and Peter DeYoung, Piramal Pharma is evolving and adapting to the increasing demands for corporate social responsibility. Their shared vision emphasizes integrating sustainability into every aspect of operations, ensuring that the company remains at the forefront of eco-friendly practices.
Future Directions for Sustainability
Piramal Pharma’s commitment to sustainability does not end with the conversion to biomass. They are actively exploring other initiatives and technologies that will further enhance their environmental footprint, creating a comprehensive approach to sustainability throughout their operations.
Frequently Asked Questions
What is the significance of converting to biomass briquettes?
The shift to biomass briquettes is crucial as it significantly reduces greenhouse gas emissions, showcasing Piramal Pharma’s commitment to environmental sustainability.
How much CO2 emission reduction is expected?
This conversion is expected to eliminate approximately 24,000 tonnes of CO2 equivalent emissions annually, contributing to the company's overall emission reduction targets.
Who are the key leaders in Piramal Pharma?
Piramal Pharma Limited is guided by influential leaders such as Nandini Piramal and Peter DeYoung, who advocate for sustainable practices within the organization.
What are the long-term goals of Piramal Pharma?
The long-term goals include achieving a 42% reduction in Scope 1 and 2 emissions by 2030 as part of their commitment to sustainability.
How is Piramal Pharma setting an industry standard?
By implementing innovative sustainable practices like the biomass conversion, Piramal Pharma is not only enhancing its operations but also setting a new benchmark for environmentally responsible manufacturing in the pharmaceutical sector.
